Sinopep-Allsino Bio Pharmaceutical Co., Ltd.SSE: 688076

Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management

Apr 30, 2026 · Issued by Sinopep-Allsino Bio Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 30, 2026 · 4 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-using-idle-self-owned-funds-for-entrusted-wealth-management-20

Release

Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix

Earlier from Sinopep-Allsino Bio Pharmaceutical

Announcement on Voluntary Disclosure of Earnings Preannouncement for Q1 2026Apr 8
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Voluntary Disclosure of Passing GMP Compliance Inspection for DrugsFeb 4
JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.: Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Feb 3
JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. Earnings Preannouncement for 2025Jan 31

Later from Sinopep-Allsino Bio Pharmaceutical

Announcement on Controlling Shareholder and Actual Controller Renewing the Agreement of Persons Acting in ConcertMay 21
Announcement on Resolutions of the 2025 Annual General MeetingMay 27
Announcement on Implementation of Dividend Distribution for 2025Jun 5
Announcement on Meeting Vesting Conditions in 3rd Vesting Period in Restricted Stock Incentive Plan 2023Jun 27
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.: Announcement on Vesting Results for the 3rd Vesting Period under the 2023 Restricted Stock Incentive Plan and the Listing of SharesJul 9

All Sinopep-Allsino Bio Pharmaceutical news releases

Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.

Follow Sinopep-Allsino Bio Pharmaceutical